Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)
China flag China · Delayed Price · Currency is CNY
8.11
0.00 (0.00%)
At close: Feb 24, 2026

SHA:603567 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
7,61710,89711,42311,98814,4129,477
Market Cap Growth
-27.34%-4.61%-4.71%-16.82%52.08%-12.40%
Enterprise Value
10,70213,76713,63613,47817,27111,076
Last Close Price
8.1111.4611.8012.3514.6810.71
PE Ratio
-24.8724.1664.6543.4021.72
Forward PE
-36.6936.6936.6936.6936.69
PS Ratio
4.784.033.642.853.492.78
PB Ratio
1.051.311.421.692.041.72
P/TBV Ratio
1.221.601.691.902.121.80
P/FCF Ratio
20.44-----
P/OCF Ratio
13.6266.32---61.07
EV/Sales Ratio
6.715.094.353.204.183.25
EV/EBITDA Ratio
-18.1937.43-42.5514.94
EV/EBIT Ratio
-22.8373.50-63.8818.92
EV/FCF Ratio
28.71-----
Debt / Equity Ratio
0.450.400.390.410.420.58
Debt / EBITDA Ratio
-4.328.38-7.234.33
Debt / FCF Ratio
8.84-----
Net Debt / Equity Ratio
0.420.270.210.260.200.30
Net Debt / EBITDA Ratio
-86.992.944.62-31.213.402.25
Net Debt / FCF Ratio
8.28-89.56-2.93-2.55-1.56-2.34
Asset Turnover
0.130.220.260.360.380.35
Inventory Turnover
0.701.212.144.073.341.80
Quick Ratio
1.222.112.161.272.041.92
Current Ratio
1.762.852.601.652.372.66
Return on Equity (ROE)
-4.32%5.34%6.17%2.70%5.30%8.14%
Return on Assets (ROA)
-0.87%2.99%0.96%-1.17%1.55%3.80%
Return on Invested Capital (ROIC)
-1.61%4.97%1.94%-1.59%2.54%7.59%
Return on Capital Employed (ROCE)
-2.10%5.90%1.90%-2.80%3.10%7.30%
Earnings Yield
-4.37%4.02%4.14%1.55%2.30%4.60%
FCF Yield
4.89%-0.23%-5.02%-6.10%-6.12%-7.53%
Dividend Yield
1.85%1.31%1.70%0.23%0.72%-
Payout Ratio
-74.00%33.48%131.34%43.28%76.15%
Buyback Yield / Dilution
0.12%0.01%0.14%-8.87%-1.82%0.01%
Total Shareholder Return
1.96%1.31%1.83%-8.64%-1.10%0.01%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.